Stealth BioTherapeutics announced the start of a new clinical trial for patients with Mitochondrial Myopathy.
On February 13, 2015, Stealth BIOTHERAPEUTICS CEO Travis Wilson detailed the new clinical trial, outlined which patients are eligible, and other important details.
CONTACT THE CLINICAL TRIAL CALL CENTER:
If you would like to download and watch the UMDF/MitoAction Joint Teleconference, click on this link.
If you would like to learn more about participation in this clinical trial VISIT www.clinicaltrials.gov and search ‘Bendavia’ or call 1-877-224-6518.
To learn more about Stealth BIOTHERAPEUTICS, click here.